Torrent Pharmaceuticals Limited has informed the Exchange regarding voting results of Court Convened General Meeting held on April 28, 2026

Nclt Scheme FiledListed Co AcquisitionStrategic Transactions View source PDF

TORNTPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+0.1%1-day move

₹4186.10

prior close

₹4220.00

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

-0.1+0.3+0.6+1.0+0.1+1.8+2.5+4.1+4.0+7.9+6.9+5.5+10.9—

Up moveDown movePending

AI summary

Torrent Pharmaceuticals Limited shareholders have approved the Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited (JB Pharma) into Torrent Pharma. The NCLT-convened meeting held on April 28, 2026 approved the merger with 100% valid votes in favor. Total valid votes polled were approximately 31.5 crore shares worth Rs 1,575 crore, with only 341 votes (0%) against the resolution. Promoter shareholders (100% in favor) and 99.33% of public shareholders voted in favor. The scheme was passed by the requisite majority as required under Section 230(6) of the Companies Act.

Likely market impact

This is a significant acquisition for Torrent Pharma as it absorbs JB Pharma, a listed pharmaceutical company. The merger will expand Torrent Pharma's product portfolio and market presence. Shareholders should monitor for regulatory approvals and the final swap ratio announcement.